Lupin receives warning letter for its Goa & Indore sites from USFDA
Lupin’s formulation manufacturing facilities at Goa and Indore (Pithampur Unit II), has received warning letter from USFDA. Earlier, Lupin received 3 Form 483 observations in Goa on...